News archive search
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
Active search
Search results
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Northrop Grumman Corporation FALLS CHURCH, Va., July 21, 2026 (GLOBE NEWSWIRE) -- Northrop Grumman Corporation (NYSE: NOC) has released its second quarter 2026 financial results. A copy of the earnings release has been furnished in the company's Form 8-K filing and is also available …
Sharemaestro market context Price below Trend Line 52 weeks -3.1%Northrop Grumman Corporation (NYSE: NOC) has released its second-quarter 2026 financial results, which are available on the company's investor relations website and through its Form 8-K filing. The company will also webcast its earnings conference call today at 9:30 a.m. Eastern time. This announcement …
Northrop Grumman reported strong Q2 2026 sales growth of 5% to $10.9 billion, driven by all four segments, and achieved a record backlog of $104.7 billion after securing $20.0 billion in net awards. Despite a 7% decrease in net earnings and a 23% fall …
Northrop Grumman (NOC) has provided its adjusted EPS guidance for 2026, projecting a range of $28.60 to $29.10. This guidance surpasses the current FactSet estimate of $27.94. The company's outlook suggests a positive financial performance for the upcoming fiscal year.
This press release announces Northrop Grumman's second quarter 2026 financial results. The document contains an embedded file with the full details of these results.
AFC Gamma (NASDAQ:AFCG) shares dropped 2.8% to $2.73 on Monday, with trading volume slightly above average. Analysts have a cautious outlook, with an average "Reduce" rating and a $4.50 price target, despite recent upgrades from Zacks and Wall Street Zen. The company maintains a …
Asking for a Trend Host Josh Lipton tees up what investors should be on the lookout for on Tuesday, July 21, including earnings from General Motors Co. (GM), Northrop Grumman Co. (NOC), and D.R. Horton Inc (DHI). Video Transcript 00:05 Speaker A Coming out …
Sharemaestro market context Price below Trend Line 52 weeks -3.1%NORTHROP GRUMMAN CORPORATION (NOC) recently disclosed $1,700,000 in lobbying expenditures for Q2 2026, focusing on defense appropriations, national security space programs, and acquisition policy. The article also details significant insider selling activity, hedge fund movements, and analyst ratings/price targets for NOC stock.
Earnings To Watch: Northrop Grumman (NOC) Reports Q2 Results Tomorrow Security and aerospace company Northrop Grumman (NYSE:NOC) will be announcing earnings results this Tuesday before the bell. Here's what investors should know. Northrop Grumman beat analysts' revenue expectations last quarter, reporting revenues of $9.88 …
Sharemaestro market context Price below Trend Line 52 weeks -3.1%Northrop Grumman (NOC) is scheduled to release its Q2 earnings on July 21st, with analysts expecting EPS of $6.82 and revenue of $10.81 billion. The company has a strong historical record of outperforming earnings expectations, boasting an 87/100 GF Score™ and a P/E ratio …
Meeder Asset Management Inc. significantly reduced its stake in Northrop Grumman Corporation by 12% in the first quarter, selling nearly 3,000 shares. Despite this, Northrop Grumman remains a key holding for Meeder, accounting for 0.9% of its investment portfolio. The aerospace company continues to …
Immatics stock (IMTX) reflects the balance between its Nasdaq-listed immunotherapy pipeline progress and a solid cash position. The company, a clinical-stage oncology biotech, relies on funding and partnerships, with recent financials highlighting collaboration revenue, research and development spending, and a multi-year cash runway. Investors …
Immatics plans to present new Phase 1b data for its lead PRAME cell therapy, anzu-cel, in metastatic cutaneous and uveal melanoma at the ESMO Congress 2026. The presentation will focus on predictors of durable response. Additionally, the company will share Phase 1 results for …
Northrop Grumman (NOC) stock is trading higher on Friday due to a market rotation into defensive sectors and anticipation of increased U.S. defense spending. Investors are shifting capital from technology stocks to defense, healthcare, and consumer staples. The company is set to release its …
Northrop Grumman and Airbus Defense and Space have signed a memorandum of understanding to explore how Northrop Grumman's Triton high-altitude, long-endurance unmanned aircraft system could fulfill NATO's future maritime surveillance requirements. This agreement aims to leverage both companies' expertise to potentially offer Triton as …
Northrop Grumman (NOC) shares rose 3.5% due to increased defense spending expectations, particularly from a proposed $1.5 trillion White House budget for fiscal 2027. The company is also seeing positive momentum from upcoming Q2 2026 financial results on July 21 and the recent groundbreaking …
Immatics (NASDAQ: IMTX) announced it will present three times at the ESMO Congress 2026, showcasing data from its PRAME-targeted pipeline, including lead cell therapies anzu-cel and IMA203CD8, and bispecific candidate IMA402. These presentations will cover Phase 1/1b trials across various solid tumors like advanced …
Immatics N.V. (IMTX) will present three key sets of data at the European Society for Medical Oncology (ESMO) Congress 2026, showcasing its PRAME-targeting therapies, including Phase 1b data for anzu-cel in metastatic melanoma, Phase 1 data for IMA203CD8 in various solid tumors, and Phase …
Immatics N.V. announced three presentations at the European Society for Medical Oncology (ESMO) Congress 2026, showcasing data from its PRAME franchise. These presentations will include Phase 1b data for anzu-cel in advanced melanoma, Phase 1 data for IMA203CD8 in various PRAME-positive solid tumors, and …
Bank of New York Mellon Corp reduced its stake in Northrop Grumman Corporation by 31.3% in the first quarter, selling 360,995 shares. Despite this, other institutional investors like Vanguard Group Inc. and New York State Teachers Retirement System increased their holdings. The report also …
This article lists various Exchange Traded Funds (ETFs) that hold stocks of Northrop Grumman Corp. (NOC). It provides a detailed table including fund symbol, market value, weight, issuer, management style, focus, expense ratio, assets under management (AUM), price, change percentage, relative volume, and 3-year …
A recent Lobbying Disclosure Act filing revealed that NORTHROP GRUMMAN SYSTEMS CORPORATION lobbied for $150,000 in Q2 2026, focusing on defense industrial base and federal government procurement issues. Insider trading activity for NOC stock in the past six months shows 33 sales and no …
Shares of Northrop Grumman Corp. (NOC) fell by 1.25% on Thursday, ending the trading session at $518.65. This decline occurred on a generally negative day for the stock market, with both the S&P 500 Index and Dow Jones Industrial Average also experiencing losses. This …
Northrop Grumman and Airbus have partnered to provide comprehensive maintenance, support, and future upgrades for NATO's fleet of MQ-4C Triton Unmanned Aerial Vehicles (UAVs). This collaboration aims to ensure the longevity and operational readiness of the Triton system for persistent maritime surveillance, with Airbus …
Northrop Grumman (NOC) recently recognized Qorvo with a 2026 Supplier Excellence Award, yet its share price has pulled back, leading to valuation questions. Despite strong long-term shareholder returns, the stock trades at a lower P/E ratio (16.8x) compared to its estimated fair P/E (28.1x) …
Sharemaestro market context Price below Trend Line 52 weeks +0.5%Search by ticker symbol or company name and select a result to open its chart.